Novel severity classification system improves treatment stratification in intestinal Behçet’s disease
Ozoralizumab showed comparable efficacy in rheumatoid arthritis patients with and without large joint involvement
Serum biomarkers identified as potential predictors of baricitinib response in juvenile idiopathic arthritis
Anti-CD38 antibody CM313 demonstrated manageable safety and encouraging efficacy in systemic lupus erythematosus
